About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The group’s basic and clinical research activity, above all, surrounds the fields of inflammation and repair, respiratory insufficiency and tissue hypoxia, and these fields complement one another and are connected through the study of conditions such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, infections, transplants, pulmonary hypertension or sleep-related breathing disorders.
The group has an experimental research laboratory and a clinical research and clinical trial unit. It is made up of professionals from different specialties (pulmonologists, biologists, nurses, laboratory technicians, physiotherapists etc.). This multidisciplinary team provides an added value to the group and guarantees the existence of the critical mass necessary to carry out scientific projects.
Our group is a node that belongs to the CIBERES network (CIBER for respiratory diseases) and also works in collaboration with groups of the highest national and international prestige.
The Group performed the first successful lung transplantation in Spain. Currently, it is one of the hospitals where the largest number of lung transplants are carried out annually, which places it among the leading centers in Europe and the world for this activity.
IP: Antonio Román Broto
The Group is considered a referral team for the diagnosis and treatment of work-related lung diseases in Catalonia, centring mainly on occupational asthma, hypersensitivity pneumonitis, and occupational disease caused by asbestos exposure. It is responsible for the creation and monitoring of the Spanish Registry of Occupational Diseases (EROL), an important task that had not been covered previously.
The Group forms a part of the Grup Col.laboratiu per la Investigació de l’Asma per Soja a Barcelona (Collaborative Research Group for Soy Asthma in Barcelona). Moreover, it is an officially accredited center to carry out daily determinations of environmental levels of soy aeroallergens in Barcelona. For this purpose, the Group has an agreement with the Servicio de Medio Ambiente del Puerto de Barcelona (Environmental Service of the Port of Barcelona), which uses the results of these analyses to monitor the unloading of soy products in the city’s port. This daily monitoring of soy aeroallergen in the city has helped the authorities been to eliminate further asthma epidemics The Group has been given several awards for its work in the area of soy asthma, such as the Fundació Cor Vilacasas award (1993), the Science Award of the City of Barcelona (1995), and the Josep Trueta Award from the Acadèmia de Ciències Mèdiques (1995).
The team also has broad experience in the study of hypersensitivity pneumonitis, with a series of 150 patients that is one of the largest in the country, given the low prevalence of this condition. In addition, our center is considered a national referral hospital for the diagnosis and treatment of this pathology. Within the research into occupational disease due to asbestos exposure, our research laboratory is the only one in Spain that carries out determinations of asbestos bodies in the lung.
IP: Fco. Javier Muñoz Gall
IP: Maria Antonia Emilia Meneghini Collaborators: Lluis Castells Fusté, Joana Sellarés Roig, Jesús Quintero Bernabeu, Eva Maria Revilla Lopez, Marina Muñoz López, Meritxell Boada Perez, Laura Donadeu Casassas, Mercedes López González Funding agency: Instituto de Salud Carlos III Funding: 111320 Reference: PI22/00749 Duration: 01/01/2023 - 31/12/2025
IP: - Collaborators: Contribución de la disfunción de CFTR al desarrollo y agresividad del cáncer de páncreas. Estimulación del crecimiento tumoral y, Eva Polverino Funding agency: Instituto de Salud Carlos III Funding: 147620 Reference: PI22/00887 Duration: 01/01/2023 - 31/12/2025
IP: Cristina Berastegui Garcia Collaborators: Carles Bravo Masgoret, Eva Maria Revilla Lopez, Meritxell Boada Perez, Susana Gómez Olles Funding agency: Instituto de Salud Carlos III Funding: 117370 Reference: PI22/01103 Duration: 01/01/2023 - 31/12/2025
IP: Susana Gómez Olles Collaborators: - Funding agency: Instituto de Salud Carlos III Funding: 60000 Reference: PI18/00035_INT_BERASTEGUI Duration: 01/01/2020 - 30/06/2023
PhD student: Eva Maria Revilla Lopez, Eva Maria Revilla Lopez Director/s: Berta Saez Gimenez, Susana Gómez Olles University: Universitat Autònoma de Barcelona Year: 2023
PhD student: Manuel López Meseguer, Manuel López Meseguer Director/s: Jaume Ferrer Sancho, Antonio Román Broto, Antonio Román Broto, Jaume Ferrer Sancho University: Universidad Autònoma de Barcelona Year: 2017
PhD student: Daniel Álvarez Simón Director/s: Fco. Javier Muñoz Gall, Mª Jesús Cruz Carmona University: Universidad Autònoma de Barcelona Year: 2017
PhD student: Gerard Muñoz Castro Director/s: Javier de Gracia Roldán University: Universidad Autònoma de Barcelona Year: 2017
PhD student: Maria Alejandra Méndez Garrido Director/s: Antonio Román Broto, Victor Monforte Torres, Antonio Román Broto University: Universidad Autònoma de Barcelona Year: 2015
The meeting, the most important event in the field worldwide, took place in Barcelona from 5 to 9 September and featured presentations of more than thirty VHIR studies.
The researcher from the VHIR Pulmonology group aims to continue promoting prevention, research and respiratory health advocacy, while strengthening the international profile of research teams in Spain and Catalonia.
The study, with the participation of VHIR, will analyse the physiological response of the human body thanks to data collected by smartwatches and wearable devices.
EXIMIOUS (Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome), un projecte finançat per la Unió Europea que engloba 15 organitzacions de 7 països europeus.
EXIMIOUS té com a objectiu estudiar l’exposoma, és a dir, l’exposició a factors ambientals al llarg de la vida, per entendre la seva relació amb les malalties immunomediades, com ara les malalties autoimmunes o les al·lèrgies. Des del VHIR està liderat per la Dra. M Jesús Cruz i el seu equip de Pneumologia.
